These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 26687144)
21. Glycobiology of α-dystroglycan and muscular dystrophy. Endo T J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372 [TBL] [Abstract][Full Text] [Related]
22. Deciphering the role of IspD (2‑C‑methyl‑D‑erythritol 4‑phosphate cytidyltransferase) enzyme as a potential therapeutic drug target against Plasmodium vivax. Saggu GS; Garg S; Pala ZR; Kochar SK; Saxena V Gene; 2018 Oct; 675():240-253. PubMed ID: 29958953 [TBL] [Abstract][Full Text] [Related]
23. Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy. Yagi H; Kuo CW; Obayashi T; Ninagawa S; Khoo KH; Kato K Mol Cell Proteomics; 2016 Nov; 15(11):3424-3434. PubMed ID: 27601598 [TBL] [Abstract][Full Text] [Related]
24. Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy. Live D; Wells L; Boons GJ Chembiochem; 2013 Dec; 14(18):2392-402. PubMed ID: 24318691 [TBL] [Abstract][Full Text] [Related]
25. Probing the stability of the "naked" mucin-like domain of human α-dystroglycan. Bozzi M; Di Stasio E; Scaglione GL; Desiderio C; Martelli C; Giardina B; Sciandra F; Brancaccio A BMC Biochem; 2013 Jul; 14():15. PubMed ID: 23815856 [TBL] [Abstract][Full Text] [Related]
26. Inhibitory machinery for the functional dystroglycan glycosylation. Kondo Y; Okajima T J Biochem; 2023 Apr; 173(5):333-335. PubMed ID: 36760122 [TBL] [Abstract][Full Text] [Related]
27. Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes. Nakamura N; Lyalin D; Panin VM Semin Cell Dev Biol; 2010 Aug; 21(6):622-30. PubMed ID: 20362685 [TBL] [Abstract][Full Text] [Related]
28. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan. Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355 [TBL] [Abstract][Full Text] [Related]
29. Protein Halmo SM; Singh D; Patel S; Wang S; Edlin M; Boons GJ; Moremen KW; Live D; Wells L J Biol Chem; 2017 Feb; 292(6):2101-2109. PubMed ID: 27932460 [TBL] [Abstract][Full Text] [Related]
30. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. Rojek JM; Spiropoulou CF; Campbell KP; Kunz S J Virol; 2007 Jun; 81(11):5685-95. PubMed ID: 17360738 [TBL] [Abstract][Full Text] [Related]
31. The structure of POMGNT2 provides new insights into the mechanism to determine the functional O-mannosylation site on α-dystroglycan. Imae R; Kuwabara N; Manya H; Tanaka T; Tsuyuguchi M; Mizuno M; Endo T; Kato R Genes Cells; 2021 Jul; 26(7):485-494. PubMed ID: 33893702 [TBL] [Abstract][Full Text] [Related]
32. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan. Praissman JL; Live DH; Wang S; Ramiah A; Chinoy ZS; Boons GJ; Moremen KW; Wells L Elife; 2014 Oct; 3():. PubMed ID: 25279697 [TBL] [Abstract][Full Text] [Related]
33. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid. Riemersma M; Sandrock J; Boltje TJ; Büll C; Heise T; Ashikov A; Adema GJ; van Bokhoven H; Lefeber DJ Hum Mol Genet; 2015 Apr; 24(8):2241-6. PubMed ID: 25552652 [TBL] [Abstract][Full Text] [Related]
34. Establishment of a novel monoclonal antibody against truncated glycoforms of α-dystroglycan lacking matriglycans. Yamasaki F; Umezawa F; Sensui T; Anzo M; Abo H; Kuo CW; Khoo KH; Kato K; Yagi H; Kawashima H Biochem Biophys Res Commun; 2021 Nov; 579():8-14. PubMed ID: 34583196 [TBL] [Abstract][Full Text] [Related]
35. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function. Imperiali M; Thoma C; Pavoni E; Brancaccio A; Callewaert N; Oxenius A J Virol; 2005 Nov; 79(22):14297-308. PubMed ID: 16254364 [TBL] [Abstract][Full Text] [Related]
36. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan. Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527 [TBL] [Abstract][Full Text] [Related]
37. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Yoshida-Moriguchi T; Campbell KP Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296 [TBL] [Abstract][Full Text] [Related]
38. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain. Breloy I; Schwientek T; Gries B; Razawi H; Macht M; Albers C; Hanisch FG J Biol Chem; 2008 Jul; 283(27):18832-40. PubMed ID: 18456664 [TBL] [Abstract][Full Text] [Related]
39. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy. Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757 [TBL] [Abstract][Full Text] [Related]
40. The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi. Ury B; Potelle S; Caligiore F; Whorton MR; Bommer GT J Biol Chem; 2021; 296():100789. PubMed ID: 34015330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]